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IFN- and -, contributing to immune defenses 
against viruses (Baranek et al., 2009). CD11b+ 
DCs preferentially prime CD4+ T cells and pro-
mote humoral immunity (Carter et al., 2006; 
Dudziak et al., 2007). CD8+ DCs are endowed 
with a unique efficiency in priming CD8+ T 
cells and in cross-presenting exogenous anti-
gens (Carter et al., 2006; Dudziak et al., 2007). 
DCs are central to immune defenses in mam-
mals. In mice, three subsets of DCs are resident 
of lymphoid organs (Crozat et al., 2010). Plasma-
cytoid DCs (pDCs) are professional producers of 
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Human BDCA3+ dendritic cells (DCs) were suggested to be homologous to mouse CD8+ DCs. 
We demonstrate that human BDCA3+ DCs are more efficient than their BDCA1+ counterparts 
or plasmacytoid DCs (pDCs) in cross-presenting antigen and activating CD8+ T cells, which is 
similar to mouse CD8+ DCs as compared with CD11b+ DCs or pDCs, although with more 
moderate differences between human DC subsets. Yet, no specific marker was known to be 
shared between homologous DC subsets across species. We found that XC chemokine receptor 1 
(XCR1) is specifically expressed and active in mouse CD8+, human BDCA3+, and sheep 
CD26+ DCs and is conserved across species. The mRNA encoding the XCR1 ligand chemokine 
(C motif) ligand 1 (XCL1) is selectively expressed in natural killer (NK) and CD8+ T lymphocytes 
at steady-state and is enhanced upon activation. Moreover, the Xcl1 mRNA is selectively 
expressed at high levels in central memory compared with naive CD8+ T lymphocytes. Finally, 
XCR1/ mice have decreased early CD8+ T cell responses to Listeria monocytogenes infection, 
which is associated with higher bacterial loads early in infection. Therefore, XCR1 constitutes 
the first conserved specific marker for cell subsets homologous to mouse CD8+ DCs in 
higher vertebrates and promotes their ability to activate early CD8+ T cell defenses against 
an intracellular pathogenic bacteria.
© 2010 Crozat et al.  This article is distributed under the terms of an Attribu-
tion–Noncommercial–Share Alike–No Mirror Sites license for the first six months 
after the publication date (see http://www.rupress.org/terms). After six months 
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presentation of soluble antigen to CD8+ T cells (unpublished 
data). In this paper, we identify the XC chemokine receptor 1 
(XCR1) as the first universal marker specifically expressed 
by the CD8+-type DCs from three different mammalian 
species: ovine CD26+ DCs, mouse CD8+ DCs, and human 
BDCA3+ DCs. We show that the Xcr1 gene is present and 
well conserved in all higher vertebrates from reptiles to   
human. The ligand of XCR1, chemokine (C motif) ligand 
1 (XCL1), is specifically expressed by activated NK and 
CD8+ T cells in mouse and human. We show that Xcl1 
mRNA  is  stored  selectively  in  memory  CD8+  T  cells,   
allowing them to rapidly produce high levels of this chemo-
kine upon stimulation. Finally, we show that XCR1/ 
mice  have  decreased  CD8+  T  cell  responses  to  Listeria 
monocytogenes  (Lm)  associated  with  higher  bacterial  loads 
early after infection. Overall, our study strongly suggests an 
important and conserved role in mammals for XCR1 in the 
cross talk between NK or CD8+ T cells and CD8+-type 
DCs, identifying this molecule as a novel tool to survey and 
target the DCs endowed with the best cross-presentation 
capacity across species.
RESULTS
Human BDCA3+ DCs are functional homologues of mouse 
CD8+ DCs for cross-presentation
To assess the cross-presentation capacity of human BDCA3+ 
DCs, we purified these cells together with other types of DCs. 
BDCA1+ DCs, BDCA3+ DCs, and pDCs were magnetically 
enriched from PBMCs by negative selection and then posi-
tively sorted by flow cytometry as depicted in Fig. 1 A. The 
purity of sorted cells was >95% as observed by postsorting 
FACS reanalysis. Sorted HLA-A2+ DC subsets were cultured 
with apoptotic uninfected, or chronically HIV-infected, H9 
cells in the presence of maturation stimuli, poly I:C for 
CD8+ DCs are required for the natural induction of strong 
CD8+ T cell responses against tumors (Hildner et al., 2008; 
Sancho et al., 2008) or West Nile virus (Hildner et al., 2008). 
Specific delivery of vaccine antigens to CD8+ DCs is espe-
cially efficient for vaccination against intracellular patho-
gens or tumors (Bonifaz et al., 2004; Nchinda et al., 2008). 
Therefore, identification of human DC subsets function-
ally homologous to mouse CD8+ DCs (CD8+-type DCs) 
should be a major step forward for the design of innovative 
vaccination or immunotherapeutic strategies against can-
cer or infections (Crozat et al., 2010). So far, no conserved 
marker has been identified to specifically and unambiguously 
define CD8+-type DCs in several mammalian species. Al-
though human BDCA3+ and mouse CD8+ DCs express the 
C-type lectin CLEC9A, which is known to be involved in 
cross-presentation in mice, this marker is also found on some 
human CD14+ monocytes and on mouse pDCs (Caminschi 
et al., 2008; Huysamen et al., 2008; Sancho et al., 2008). It is 
of note that no orthologue of CLEC9A has been identified 
yet in non mammalian vertebrate species.
We have recently performed comparative genomics stud-
ies of human, mouse, and sheep DC subsets to help identify 
potential homologies between these cell types across mam-
malian species (Robbins et al., 2008; unpublished data). We 
found that human blood BDCA3+ DCs share a specific gene 
signature with mouse CD8+ DCs and proposed that they 
could be human professional cross-presenting DCs (Robbins 
et al., 2008; Crozat et al., 2010). In this paper, we demon-
strate that human BDCA3+ DCs are more potent than their 
BDCA1+ counterparts or than pDCs for CD8+ T cell activa-
tion through antigen cross-presentation. We established else-
where  that  sheep  lymph  CD26+  DCs  (Epardaud  et  al., 
2004) are also equivalents to mouse CD8+ DCs based on 
gene expression and functions such as superior efficacy for 
Figure 1.  Human blood BDCA3+ DCs are endowed 
with a higher cross-presentation ability than 
BDCA1+ DCs and pDCs. (A) Sorting of DC populations 
from PBMCs. First, CD3 and CD14-depleted PBMCs were 
gated based on SSC-W and SSC-A to exclude cellular 
doublets and on FSC-A and SSC-A. Next, CD19HLA-DR+ 
events and CD14CD16 events were sequentially se-
lected. HLA-DR+CD123hi events, corresponding to pDCs, 
were then sorted and the remaining events falling in the 
HLA-DR+CD123lo/ were distinguished for BDCA1+ DC 
and BDCA3+ DC sorting. Sorting gates are delineated by 
red lines. (B) Cross-presentation assay with human DCs. 
Purified BDCA1+ DCs, BDCA3+ DCs, and pDCs were cul-
tured with apoptotic cells at a 1:1 ratio for 16 h in the 
presence of maturation signal, 100 ng/ml LPS, 10 µg/ml 
poly I:C, or 10 µM R848 as indicated. After loading, DCs 
were extensively washed and used (5,000/well) in a 16-h 
IFN- ELISPOT assay with HIV-specific CD8+ T cells lines 
as effectors (15,000/well). Data are presented as the 
mean and range of duplicate wells for one representative 
experiment of at least two.JEM VOL. 207, June 7, 2010 
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BDCA3+ DCs, LPS or poly I:C for BDCA1+ DCs, and R848 
for pDCs. They were then cultured with an HIV-1 Pol-
specific CD8+ T cell line. To avoid viral replication, experi-
ments were performed in the presence of Saquinavir, an HIV 
protease inhibitor (Hoeffel et al., 2007). BDCA3+ DCs in-
duced 40% more IFN- ELISPOTs than poly I:C–stimulated 
BDCA1+ DCs or R848-stimulated pDCs and 60% more as 
compared with LPS-stimulated BDCA1+ DCs (Fig. 1 B). 
Therefore, as expected from their gene expression profile 
(Robbins et al., 2008; Crozat et al., 2010), human BDCA3+ 
DCs had higher cross-presentation capacities than other 
human blood DC subsets and represent functional homo-
logues of mouse CD8+ DCs for cross-presentation.
XCR1 is selectively expressed by mouse CD8+, human 
BDCA3+, and sheep CD26+ DCs
Based on gene chip analyses, the expression of the XCR1 
gene is a selective marker for both human BDCA3+ DCs and 
mouse CD8+ DCs when compared with a large panel of cell 
types, including other DC subsets, a variety of other leuko-
cytes and of nonhematopoietic cells, and all types of tissue 
(Fig. 2 A). This contrasts with the markers currently used to 
identify these DC subsets, which are more broadly expressed 
as clearly evident for BDCA3 in human or CADM1 in human 
Figure 2.  Xcr1 gene expression by different subsets of immune 
cells isolated from mice, human, and sheep. (A) Microarray analysis of 
the expression of the XCR1, THBD (BDCA3), CADM1, and LILRA4 (BDCA2) 
human genes and of the Xcr1, CD8a, Cadm1, and Siglech mouse genes in 
96 different cell types or tissues, in human (top) and mouse (bottom), 
respectively. The human data were retrieved from the GEO database,  
normal tissues and cell types from the GSE7307 dataset, PBMC-derived 
macrophages from GSE4883, monocyte-derived DCs from GSE7509, 
monocyte-derived macrophages from GSM213500, and alveolar macro-
phages from GSE2125, and blood and tonsil DC subsets were retrieved 
from the E-TABM-34 dataset (Lindstedt et al., 2005) of the EBI Array-
Express database. The data for the other leukocyte subsets directly iso-
lated from normal human blood were described previously (Du et al., 
2006; Robbins et al., 2008) and can be downloaded from http://www- 
microarrays.u-strasbg.fr/files/datasetsE.php. The data for the mouse were 
downloaded from the BioGPS public database (http://biogps.gnf.org). 
Green circles, pDCs (dark, blood; light, tonsil); red circles, mouse spleen 
CD8+ DCs and human blood BDCA3+ DCs; orange circles, human tonsil 
BDCA3+ DCs; blue circles, mouse spleen CD11b+ DCs or human BDCA1+ 
DCs (dark, blood; light, tonsil); brown circles, mouse spleen; yellow circles, 
mouse lymph nodes; gray, all other cell types and tissues. Results are 
expressed as mean and SD for at least three independent values for most 
human data points. (B) Xcr1 expression determined by real-time PCR on 
sorted mouse spleen DC subsets and sheep leukocytes. Mouse DCs were 
defined as linCD11c+Bst2+ for pDCs, linCD11c+Bst2CD8+ for CD8+ 
DCs, and CD8 for CD11b+ DCs. Results are representative of at least 
two independent experiments. Sheep skin lymph CD1b+CD26+ and 
CD1b+CD26 DCs were sorted by flow cytometry to >99% purity. Sheep 
CD4+ T, CD8+ T, NK, and B cells were purified from afferent lymph, and 
CD14+ monocytes from blood, by flow cytometry sorting to >95% purity. 
Results are mean ± SEM of triplicate real-time RT-PCR reactions and they 
are representative of two different sheep for lymphocytes and of three 
different sheep for DCs. (C) -galactosidase expression in splenocytes 
from XCR1+/+ and XCR1/ mice. -galactosidase expression was as-
sessed by FDG staining. The results are shown from one mouse represen-
tative of at least eight animals studied in four independent experiments.
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in NK and CD8+ T cells already at steady state not only in 
mouse and human (Fig. 4 B) but also in sheep (Fig. 4 C). 
Moreover,  similar  to  what  we  previously  reported  for 
CCL5 (Walzer et al., 2003), we show that XCL1 mRNA 
is selectively expressed to high levels in antiviral central 
memory CD8+ T lymphocytes (TCMs) and, to a lesser extent, 
in memory T cells induced by sterile inflammatory condi-
tions (inflammatory memory CD8+ T cells [TIMs]; Fig. 4 D). 
Cytokine secretion profiling of the mouse CD8+ T cell 
subsets demonstrated a rapid and higher level secretion of 
XCL1  by  TIM  after  antigen-specific  reactivation  in  vitro 
compared with naive CD8+ T cells (unpublished data). The 
selective expression of Xcl1 in mouse TCM was confirmed 
independently by mining published mouse microarray data-
sets retrieved through the GEO database (Sarkar et al., 2008; 
Fig. S1 A). Therefore, XCL1 mRNA is specifically ex-
pressed at steady state in NK and, to a lesser extent, CD8+ T 
cells, further induced in these cell types upon activation, in-
cluding during viral infections in mouse and human (Fig. S1; 
Hyrcza et al., 2007; Sarkar et al., 2008), and stored in TCM. 
Hence, XCR1 expression is likely integral to the unique po-
tency  of  CD8+-type  DCs  for  interaction  with  NK  and 
CD8+ T cells.
and mouse (Fig. 2 A). Further extending this striking convergent 
observation in mouse and human DCs, we found that in a 
distant mammalian species, i.e., sheep, the XCR1 gene was 
also  selectively  expressed  in  the  CD8+-like  skin  lymph 
CD26+ DC (Fig. 2 B). Thus, among the genes differentially 
expressed between DC subsets in a conserved manner across 
the three mammalian species examined, the XCR1 gene 
stands out as the most discriminating marker for mouse 
spleen  CD8+  DCs,  human  blood  BDCA3+  DCs,  and 
sheep lymph CD26+ DCs (Fig. 2, A and B). This is also the 
case for tonsil BDCA3+ DCs (Fig. 2 A, orange circle). Xcr1 
mRNA was also selectively expressed in CD11c+SIRPCD24+ 
cells from BM FLT3-L cultures (Fig. 3 A), which corre-
spond to a subset of in vitro–derived DCs equivalent to 
spleen CD8+ DCs which can be referred to as eCD8+ 
DCs (Naik et al., 2005).
To assess XCR1 protein expression pattern on mouse 
leukocytes, we resorted to a reporter/knockout mouse strain 
expressing the -galactosidase enzyme under the control of 
the Xcr1 promoter. When total spleen leukocytes were iso-
lated from XCR1/ mice and stained for -galactosidase 
activity using fluorescein di--d-galactopyranoside (FDG) as 
a substrate, >80% of the cells that stained positive with FDG 
were CD8+ DCs, and >75% of CD8+ DCs were FDG+ 
(Fig. 2 C). Thus, Xcr1 was confirmed to be expressed selec-
tively by the majority of mouse CD8+ DCs. Altogether, 
these results showed that XCR1 is a conserved and very dis-
criminating marker for the identification of mouse, ovine, 
and human CD8+-type DCs.
XCR1 protein is active on mouse CD8+, human BDCA3+, 
and sheep CD26+ DCs
We then performed transwell migration assays with recombi-
nant XCL1 and mixtures of the three subsets of mouse spleen 
DCs (Fig. 4 A) or their in vitro equivalents derived in BM 
FLT3-L cultures (Fig. 3 B). In both instances, XCL1 induced 
the specific migration of CD8+-type DCs. Moreover, only 
XCR1+/+ and XCR1+/ CD8+ or eCD8+ DCs were re-
sponsive to XCL1 (Fig. 3 B and Fig. 4 A), but not their 
XCR1/ counterparts, demonstrating that XCR1 is required 
for DC responses to XCL1. We then performed transwell as-
says with enriched DC preparations from human blood and 
sheep lymph. Only human BDCA3+ DCs and sheep CD26+ 
DCs, and none of the other leukocyte subsets tested, were 
found to migrate in response to XCL1 (Fig. 4 A). Therefore, 
XCR1 is required for DC responses to XCL1, and its en-
gagement induces the selective motility of mouse, ovine, and 
human CD8+-type DCs.
Xcl1 mRNA is stored in quiescent NK cells and memory 
CD8+ T lymphocytes
XCL1  is  produced  and  secreted  specifically  by  activated 
mouse and human NK and CD8+ T cells (Müller et al., 
1995; Dorner et al., 2002), whereas no XCL1 protein is de-
tected by intracellular staining in quiescent mouse NK cells 
(Dorner et al., 2002). The Xcl1 gene is specifically expressed 
Figure 3.  XCR1 expression and functions on mouse DC subsets 
from BM FLT3-L cultures. (A) DC subsets from FLT3-L BM cultures 
from C57BL/6Ncrl mice were sorted and examined by real-time PCR for 
expression of the Xcr1 gene. (B) Transwell assay on DC subsets derived 
from FLT3-L cultures of XCR1+/ and XCR1/ BM cells. Results are rep-
resentative of two experiments and expressed as mean ± SEM from 
duplicate wells for each data point. eCD8+: FLT3-L BM-DC equivalents 
to spleen CD8+ DCs and defined as SIRPCD24+CD11c+ cells. 
eCD11b+: FLT3-L DC equivalents to spleen CD11b+ DCs and defined  
as SIRP+CD24CD11c+ cells. pDC: FLT3-L BM-pDC defined as  
CD11clowSiglec-H+ cells.JEM VOL. 207, June 7, 2010 
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true orthologues of the mammalian Xcr1 gene (Fig. 5 A 
and Fig. S2), which was confirmed by synteny (Fig. 5, B 
and C). The multiple genes found in fish probably de-
rive from the complex history of fish genomes that 
have been marked by large duplication events, fast evo-
lution, and extensive genome rearrangements (Ravi and 
Venkatesh, 2008). It is remarkable that both stickleback 
Xcr1 co-orthologues are closely linked to paralogues of 
the marker FYCO1, which is also encoded in the close 
neighborhood of mammalian Xcr1 (Fig. 5 B-C). This con-
served synteny indicates that the stickleback Xcr1-like 
genes indeed constitute valid co-orthologues of the mammalian 
receptor. Hence, XCR1 is a promising candidate marker 
to identify, isolate, study, and possibly target CD8+-type 
DCs in all vertebrates.
XCR1 promotes induction of CD8+ T cell responses and control 
of bacterial load in vivo early during Lm infection
CD8+ DCs, but not CD11b+ DCs or pDCs, isolated from 
mice infected with Lm present bacterial antigens for the 
priming of naive CD8+ T cells (Belz et al., 2005). Treat-
ment of Lm-infected mice with pertussis toxin compromises 
the later activation of adoptively transferred antibacterial CD8+ 
T cells (Aoshi et al., 2008). Pertussis toxin is a nonspecific 
inhibitor of G proteins that is widely used to inhibit chemo-
kine receptor signaling. Thus, it was suggested that a che-
mokine receptor expressed on DCs is required to enable them 
to induce CD8+ T cell responses to Lm infection. We rea-
soned that XCR1 could contribute to this process. Therefore, 
Xcr1 is conserved in vertebrates and may be an ancient 
marker for CD8+-type DCs.
Sequences similar to the Xcr1 locus are available from many 
mammals including all the species with a full genome assem-
bly. Only one gene per species was found, located in the 
same genomic region as several CC chemokine receptors 
(CCRs). A unique Xcr1 sequence was also identified from 
genomes of birds and the Anole lizard. Several sequences 
similar to Xcr1 were present in teleost fish, such as zebrafish 
and stickleback, but only one in others like Fugu. The Xcr1 
sequence is well conserved in all eutherian species examined 
(>75% identity with the human sequence), in marsupials 
(70% identity), in birds and reptiles (60–65% identity), 
and in fish (50–60% identity; Fig. S2). These sequences were 
aligned with those of several human CCRs, and phyloge-
netic analyses were performed using different methods. Trees 
reconstructed were congruent and demonstrated that the 
Xcr1-like sequences found in the different vertebrate taxa are 
Figure 4.  XCR1 is functionally active on mouse CD8+,  
human BDCA3+, and sheep CD26+ DCs, and Xcl1 mRNA is 
stored in quiescent NK cells and memory CD8+ T lymphocytes. 
Transwell migration assay on enriched human blood DCs or lympho-
cytes, sheep lymph CD26+ versus CD26 DCs, and splenic DCs from 
XCR1/ and C57BL/6NCrl (XCR1+/+) mice. Results are representative 
of at least two independent experiments for each species and ex-
pressed as mean ± SEM from duplicate wells for each data point.  
(B) Expression of the XCL1 gene in human and mouse cell types and 
tissues, based on the same gene chips data as used in Fig. 1 A, with 
the following additions: black triangles, NK cells; purple triangles, 
resting peripheral CD8+ T cells; purple diamond, anti-CD3 activated 
human T cells; purple square, mouse CD8+ thymocytes; violet 
square, mouse CD4+ thymocytes. Results are expressed as mean and 
SD for at least three independent values for most human data 
points. (C) Expression of the XCL1 gene in sheep leukocytes as assessed 
by real-time PCR on the same lymph or blood cells as shown in Fig. 2. 
Results are mean ± SEM of triplicate real-time RT-PCR reactions, 
and they are representative of two different sheep for lymphocytes 
and of three different sheep for DCs. (D) Results of Xcl1 gene ex-
pression in mouse CD8+ T cell subsets. Xcl1 expression was mea-
sured by real-time PCR on sorted naive or TIM, or antiviral TCM CD8+ 
T cell subsets. Expression of Ccl5 and Ifng were also evaluated as 
controls, as the genes are expressed to higher levels in memory 
CD8+ T cells (Walzer et al., 2003). Results are represented  
as mean ± SD for mean values from duplicate real-time PCR reactions 
performed on mRNAs from naive T cells or from TIM from three  
individual mice each, and from TCM from four individual pools of 
seven mice.1288 XCR1 is a conserved DC subset-specific marker | Crozat et al.
we challenged XCR1/ and XCR1+/+ mice with Lm to 
evaluate the impact of XCR1 deficiency on the control of 
the bacteria load and on the induction of CD8+ T cell responses 
(Fig. 6). As compared with XCR1+/+ mice, XCR1/ animals 
infected with WT Lm displayed a log increase in their bac-
teria loads measured in livers and spleens at day 3 after in-
oculation (Fig. 6 A). There was still a trend toward higher 
bacterial loads in the spleen and liver of XCR1/ mice at 
day 4 after inoculation, although it was weaker than at day 
3 (unpublished data). Because anti-Lm CD8+ T cell responses 
are readily detectable at 3–4 d after infection (Khanna et al., 
2007), their alteration in XCR1/ animals could contrib-
ute to the higher bacterial replication in these animals. To 
compare the levels of anti-Lm CD8+ T cell responses between 
XCR1/ and XCR1+/+ mice, they were infected with a 
recombinant Lm strain expressing the ovalbumin antigen 
(Lm-OVA), and anti-OVA CD8+ T cells were enumerated 
by MHC class I tetramer staining at day 4 after inoculation. 
XCR1/ mice exhibited significantly fewer anti-Lm CD8+ 
T cells than XCR1+/+ animals (Fig. 6 B). Thus, these data 
suggest that XCR1 activity in CD8+ DCs allows them to 
more efficiently induce antigen-specific CD8+ T cell responses 
and, hence, promote bacteria control early after infection 
with Lm.
Figure 5.  Xcr1 evolution in vertebrates. (A). Neighbor-joining (NJ) 
phylogenetic analysis. Xcr1 sequences from selected vertebrate species 
were extracted from the Ensembl databases and aligned with relevant 
human CCR sequences using ClustalW. The evolutionary history was in-
ferred using the NJ method. The bootstrap consensus tree inferred from 
1,000 replicates is taken to represent the evolutionary history of the taxa 
analyzed. The percentages of replicate trees in which the associated taxa 
clustered together in the bootstrap test are shown next to the branches. 
The tree is drawn to scale, with branch lengths in the same units as 
those of the evolutionary distances used to infer the phylogenetic tree. 
The evolutionary distances were computed using the Poisson correction 
method and are in the units of the number of amino acid substitutions 
per site. All positions containing gaps and missing data were eliminated 
from the dataset (complete deletion option). There were a total of 267 
positions in the final dataset. Phylogenetic analyses were conducted in 
MEGA4 (Tamura et al., 2007). Abbreviations for species are: HS, Homo 
sapiens (Ensembl ID: ENSG00000173578); BT, Bos taurus (ENS-
BTAG00000020019); MM, Mus musculus (ENSMUSG00000060509); FR, 
Fugu rubripes (ENSTRUG00000012394); GG, Gallus gallus (ENS-
GALG00000011735); MD, Monodelphis domestica (ENS-
MODG00000024025); TG, Taeniopygia guttata (ENSTGUG00000004516); 
DR, Danio rerio (ENSDARG00000054847, ENSDART00000077124, and 
ENSDART00000074943); and GA, Gasterosteus aculeatus (ENS-
GACG00000011742 and ENSGACG00000017177). Human CCR IDs are as 
follows: CX3CR1 (ENSG00000168329); CCR8 (ENSG00000179934); CCR4 
(ENSG00000183813); CCR1 (ENSG00000163823); CCR3 
(ENSG00000183625); CCR2 (ENSG00000121807); and CCR5 
(ENSG00000160791). (B) Map of the human genes in the vicinity of the 
XCR1 gene. (C) Conserved syntenies retrieved in different vertebrates in 
the neighborhood of Xcr1. Abbreviations for species are the same as in  
A. The locations of the genes are given as the number of the correspond-
ing chromosome (for mammals and birds) or linkage group (for teleost), 
followed by a colon and the position of the sequence in base pairs on the 
chromosome/group.
 
Figure 6.  XCR1 deficiency affects Lm control and antibacterial 
CD8+ T cell responses early after infection. (A) Bacterial loads in the 
spleen and liver of XCR1/ versus XCR1+/+ mice at day 3 after infection. 
Results are represented as mean ± SEM for three animals per group and 
from one representative experiment out of two. (B) Frequency of anti-
OVA(SIINFEKL) tetramer+ cells within total spleen CD8+ T lymphocytes 
from Lm-OVA–infected mice at day 4 after infection. Results are repre-
sented as mean ± SEM from two independent experiments pooled for 
statistical analysis. ***, P < 0.005 using an unpaired Mann-Whitney non 
parametric test, eight mice per group.JEM VOL. 207, June 7, 2010 
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CD8+-type DCs derived in vitro in mouse BM FLT3-L 
cultures or isolated ex vivo from human and sheep. In our 
hands, XCL1 did not induce any maturation of DCs, either 
alone or in combination with IFN-, and did not seem to af-
fect TLR-induced maturation of DCs in vitro (unpublished 
data). We confirm the specific expression of XCR1 ligands 
in NK cells and CD8+ T lymphocytes in mouse and human 
and extend it to sheep. We show that Xcl1 mRNA is stored 
in quiescent NK cells and antiviral memory CD8+ T lym-
phocytes. We show that XCR1 promotes the induction of 
CD8+ T cell responses and the control of bacterial load in 
vivo early during Lm infection. Our phylogenetic analyses 
show the presence of a unique and well conserved XCR1 
orthologue in all higher vertebrates from reptiles to human. 
Altogether,  these  observations  strongly  suggest  that  the 
XCL1→XCR1 chemotactic pathway constitutes one of the 
critical and conserved molecular bases promoting selective 
and efficient cross talk between CD8+-type DCs and CD8+ 
T lymphocytes as well as NK cells.
In summary, our results demonstrate a functional homol-
ogy between mouse CD8+, sheep CD26+, and human 
BDCA3+ DCs and identify XCR1 as the best candidate to 
date for the identification of CD8+-type DCs in all verte-
brates, with a very narrow expression pattern highly restricted 
to these cell types. In addition, we show that, contrary to 
the molecules classically used to identify CD8+-like DCs, 
XCR1 is not a mere phenotypical marker of these cells but 
actually contributes to confer on them their exquisite ability 
for CD8+ T cell activation. Thus, our study brings signifi-
cant advances toward the generation of a unifying pheno-
typic and functional view of mammalian DC subsets, with 
major implications both for basic and applied immunology. 
Our findings open a way for the general survey by immuno-
histofluorescence of the anatomical location of CD8+-type 
DCs and for their specific targeting in vivo for vaccination 
against intracellular pathogens or tumors threatening human 
or domestic animal health.
MATERIALS AND METHODS
Cell  purification  and  culture  for  human  DC  subset  cross- 
presentation assay. For each experiment, >500 × 106 PBMCs were iso-
lated by Ficoll-Hypaque density gradient centrifugation (GE Healthcare) 
from peripheral blood cytapheresis residues obtained from normal healthy 
volunteer donors through the Etablissement Français du Sang according to 
the French ethics committee on human experimentations, within a conven-
tion with Institut National de la Santé et de la Recherche Médicale. Primary 
DCs (BDCA1+ DCs, BDCA3+ DCs, and pDCs) were isolated from PBMCs 
depleted of CD3+ and CD14+ cells using CD3+ and CD14+ MACS microbeads 
and an AutoMACS (Miltenyi Biotec). Enriched cells were labeled and 
DCs were sorted on a FACSAria flow cytometer (BD) as events negative for 
CD14,  CD16,  and  CD19  and  positive  for  HLA-DR  and  BDCA1  for 
BDCA1+ DCs, HLA-DR and BDCA3 for BDCA3+ DCs, or HLA-DR and 
CD123 for pDCs. The following antibodies were used: HLA-DR-PerCp 
(G46-6), CD14-PE-Cy7 (M5E2), CD16-APC-H7 (3G8; all obtained from 
BD), CD19-ECD (J3-119; Beckman Coulter), BDCA1-Pacific Blue (L161; 
BioLegend), BDCA3-APC (AD5-14H12), and CD123-PE (AC145; both 
obtained from Miltenyi Biotec). Cell sorting gave a purity >95%. CD8+ pri-
mary T cell lines specific for the HLA-A2–restricted HIV-Pol476-84 epitope 
DISCUSSION
The demonstration that human blood BDCA3+ DCs isolated 
ex vivo are more potent than their BDCA1+ counterparts or 
pDCs for antigen cross-presentation and CD8+ T cell activa-
tion fulfills our prediction, based on our comparative genom-
ics studies, that human BDCA3+ DCs represent, in this 
respect, a functional homologue of mouse CD8+ DCs and 
an interesting target for the design of innovative vaccination 
or immunotherapeutic strategies against infections by intra-
cellular pathogens or cancer (Robbins et al., 2008; Crozat et al., 
2010). More generally, our results demonstrate a common 
specialization of mouse CD8+, human BDCA3+, and sheep 
CD26+ DCs for CD8+ T cell activation through cross-
presentation of exogenous antigens and identical high selec-
tive expression of XCR1 by these cells that is consistent with 
the role of this molecule in the promotion of the interac-
tions between CD8+-like DCs and CD8+ T cells. These 
results establish a definitive proof of concept that validates 
our comparative genomics approach to hunt for conserved 
functions based on conserved molecular pathways for DC 
subsets  across  several  mammalian  species  (Robbins  et  al., 
2008; Crozat et al., 2010).This work exemplifies how critical 
knowledge can be gained to understand important immuno-
logical processes by using comparisons between species as a 
tool and by developing tight collaborations between teams 
working  with  different  animal  models.  In  particular,  this 
work illustrates the utility of nonprimate animal models for 
understanding human immunology, provided that a rational 
approach is followed to help focusing on conserved biologi-
cal processes and molecular functions.
Based on gene chip analyses, we previously reported that 
mouse CD8+ DCs specifically expressed the Xcr1 gene, to 
high levels, whereas none of the other leukocyte subsets ex-
amined did. Indeed, in the Supplemental material of our pa-
per (Robbins et al., 2008), we reported Xcr1 as the third most 
specific gene for mouse CD8+ DCs in our analyses. This 
result was confirmed and significantly extended by Dorner 
et al. (2009). Indeed, these authors additionally reported that 
XCR1 engagement induces calcium mobilization specifically 
in CD8+ DCs and that XCL1 responses are required for the 
induction of optimal primary CD8+ T cell responses by 
CD8+ DCs in response to soluble model antigens in vitro 
and in vivo. No functional ProbeSet specific for the human 
XCR1 gene had been identified on the Affymetrix Human 
Genome U133 Plus 2.0 Array until very recently. XCR1 
was, therefore, not reported by us (Robbins et al., 2008) or 
by Dorner et al. (2009) to be specifically expressed in human 
BDCA3+ DCs. However, by mapping on the human genome 
all individual orphan ProbeSets that were giving a high and 
specific signal only in human BDCA3+ DCs as compared 
with other blood leukocyte subsets, we identified that the 
1561226_at ProbeSet mapped to the human XCR1 gene, 
which was later confirmed by the November 2009 update of 
the Ensembl genome browser. Hence, we demonstrate in 
this paper, for the first time, to the best of our knowledge, a 
conserved  specific  expression  and  activity  of  XCR1  on 1290 XCR1 is a conserved DC subset-specific marker | Crozat et al.
(ST4; Hopkins, 1991), CD14 (CAM36A; Berthon and Hopkins, 1996), and 
NKp46 (AKS4). AKS4 was produced against bovine NKp46 according 
to a previously described protocol (Storset et al., 2004), and it cross re-
acts with ovine NK cells defined as CD16+/CD14 blood leukocytes 
(Elhmouzi-Younes et al., 2010). NKp46 has been shown to be the best 
discriminating and conserved marker for NK cell identification in mam-
mals (Storset et al., 2004; Walzer et al., 2007). The DU2-104 mAb is used 
to characterize all B cells in sheep (Press et al., 1993). Sheep cells were reacted 
with 2 µg/ml of primary antibodies, stained with fluorochrom-conjugated 
purified Ig directed to specific mouse isotypes, and sorted by FACS with 
>95% purity.
Microarray and real-time PCR experiments. The generation and anal-
ysis of microarray data for mouse and human DC subsets were described 
elsewhere (Robbins et al., 2008; Zucchini et al., 2008). All datasets used 
are public and their references for download from databases are given in 
the legends of figures. A compendium of human hgu133plus2 Affymetrix 
.CEL files was established, using Bioconductor (release 2.5) in the R sta-
tistical environment (version 2.10.1). This consisted of the quality control 
assessment using the AffyPLM package (Bolstad et al., 2004; e.g., visual ex-
amination of hybridization chip images, relative log expression, and nor-
malized unscaled standard errors plots) and the robust multichip analysis 
normalization (Irizarry et al., 2003) with the Affy package. Normalized log2 
scaled values were then averaged among replicate arrays for each probe, 
and standard deviations were calculated. For real-time PCR experiments, 
total RNA was prepared with either the RNA NOW reagent (Biogentex) 
for mouse CD8+ T cells or the RNeasy Isolation kit (QIAGEN) for mouse 
DCs. RNA was reverse transcribed into cDNA with the QuantiTect re-
verse transcription kit (QIAGEN), and the cDNA was analyzed by real-time 
PCR using the Power SYBR green PCR master mix (Applied Biosystems). 
Primers  were  as  follows:  mouse  Xcr1,  5-CTCAGCCTTGTGGGTAA-
CAGC-3  and  5-ACAGGCAGTAGACAGGAGAAC-3;  mouse  Ccl5, 
5-GCACCTGCCTCACCATATGG-3  and  5-AGCACTTGCT-
GCTGGTGTAG-3;  mouse  Ifng,  5-CCAGCGCCAAGCATTCAAT-
GAG-3 and 5-GACAATCTCTTCCCCACCCCG-3; mouse ubiquitin, 
5-AAGAATTCAGATCGGATGACACACT-3  and  5-GCCACTT-
GGAGGTTGACACTTT-3;  sheep  XCR1,  5-TGCCATCTTCCA-
CAAGGTGTT-3 and 5-ACGGAGGCGAGGAACCA-3; sheep XCL1, 
5-TGAGCCAGAGCAAGCCTACA-3  and  5-TCACTACCCAGT-
CAGGGTCACA-3;  and  sheep  GAPDH,  5-CACCATCTTCCAG-
GAGCGAG-3  and  5-CCAGCATCACCCCACTTGAT-3.  Relative 
gene expression was calculated using the Ct method with b-actin for 
mouse DCs, ubiquitin for mouse CD8+ T cells, and GAPDH for sheep 
leukocytes as the endogenous control housekeeping genes.
Transwell migration assay. Mouse DCs were obtained by density gradient 
enrichment from splenocytes or derived in vitro from BM Flt3-L cultures as 
previously described (Sjölin et al., 2006). Human DCs were enriched using 
the human Blood Dendritic Cell Isolation kit II (Miltenyi Biotec). Sheep 
DCs were enriched by density gradient. Cells were resuspended in migration 
medium (0.5% BSA in RPMI) and distributed in the upper chamber of a 24 
Transwell system insert (5-µm pore size; Corning). The lower chamber was 
filled with migration medium alone or containing 300 ng/ml of mouse 
recombinant XCL1 (R&D Systems) for mouse cells, 500 ng/ml of human 
recombinant XCL1 (R&D Systems) for human cells, and 100 ng/ml of re-
combinant mouse XCL1 for sheep cells. Cells were incubated for 3–4 h at 
37°C in 5% CO2. A constant number of polybead polystyrene microspheres 
(Polyscience) was added in each lower chamber before harvesting migrated 
cells. Migrated cells were then stained and analyzed by flow cytometry. A 
constant event of microspheres for each well was acquired to evaluate the 
absolute number of cells recovered after migration. The percentage of mi-
grated cells was calculated by the following formula for each subset: [number 
of cells having migrated in response to XCL-1  number of cells having mi-
grated spontaneously]/[total number of input cells] × 100. All experiments 
were performed with duplicate wells.
were generated as previously described (Hoeffel et al., 2007) using PBMCs 
from HLA-A2+ HIV+ individuals from a cohort study with the approval of 
Cochin Hospital’s ethics committee. They were cultured in the presence of 
1 µM Pol476-484 in complete medium (CM; RPMI 1640–GlutaMAX con-
taining 100 U/ml penicillin, 100 mg/ml streptomycin, 1% nonessential 
amino acids, 1 mM sodium pyruvate, and 10 mM Hepes buffer; Life Tech-
nologies) + 5% human serum (BioWest) and maintained for 4 wk at 0.7 × 
106–106 cells/ml, adding 10 U/ml IL-2 (Roche) twice a week. Uninfected 
(American  Type  Culture  Collection;  HTB-176)  or  chronically  infected 
(American Type Culture Collection; CRL-8543) HLA-A2 H9 cells were 
UV-irradiated (400 mJ/cm2 at 312 nm) to induce their apoptosis and incu-
bated at 106 cells/ml for 2 h in CM + 10% FCS (Invitrogen). Purified 
BDCA-1+ DCs, BDCA-3+ DCs, and pDCs were cultured with apoptotic 
cells at a 1:1 ratio for 16 h in the presence of a maturation signal, 100 ng/ml 
LPS (Sigma-Aldrich), or 10 µg/ml poly I:C (InvivoGen) or 10 µM R848 
(InvivoGen) in CM + 5% human AB serum. After loading, DCs were ex-
tensively washed and used (5,000/well) in a 16-h IFN- ELISPOT assay 
with HIV-specific CD8+ T cells lines as effectors (15,000/well). All cultures 
were performed in the presence of 1 µM Saquinavir (Roche), an HIV-
protease inhibitor, to avoid HIV replication (Hoeffel et al., 2007).
Animals. C57BL/6Ncrl mice were provided by Charles River. XCR1/ 
mice  (B6.129P2-Xcr1<tm1Dgen>/J  mice;  MGI:3604538)  were  generated  by 
Deltagen. Frozen XCR1+/ embryos were provided by The Jackson Labo-
ratory for strain reviviscence in the Centre d’Immunologie de Marseille-
Luminy (CIML). In these mice, the -galactosidase is expressed under the 
Xcr1 promoter and in place of Xcr1, which permits a detection of the natural 
expression pattern of Xcr1. All mice were kept under pathogen-free condi-
tions in the CIML animal care facility. Mouse experiments were conducted 
in accordance with institutional guidelines for animal care and use (French 
Provence Ethical Committee Protocol no. 04/2005 and US Office of Labo-
ratory Animal Welfare Assurance A5665-01). Sheep were cannulated at the 
Center of Research in Interventional Imaging, Institut National de La 
Recherche Agronomique-Assistance Publique Hôpitaux de Paris (Jouy en 
Josas, France) for collecting prescapular skin afferent lymph as previously de-
scribed (Schwartz-Cornil et al., 2006), and the sheep were housed in the 
Domestic Animal Experimental Unit INRA (Paris-Sud ethic commitee no. 
08002A, Jouy en Josas, France).
Memory CD8+ T cell generation. TIMs were generated by intraperito-
neal injection of 50 nmol influenza A nucleoprotein NP366-374 in PBS 
in naive thymectomized transgenic F5 mice (Mbitikon-Kobo et al., 2009). 
Antiviral TCMs were generated by immunizing F5 mice with a recombinant 
vaccinia virus including the NP68 epitope as previously described (Cottalorda 
et al., 2009). Spleens and lymph nodes were collected 6 wk after infection 
for cell preparation as described in the next section.
Cell preparation, staining, and cell sorting for real-time PCR or 
transwell migration assay. Mouse splenocytes were prepared and DC 
subsets sorted as described previously (Robbins et al., 2008). CD8+ T cells 
purified from mouse spleen and lymph nodes were stained for surface ex-
pression of CD44, CD8, and F5 TCR (Walzer et al., 2002). Naive CD8+ 
T cells, TIM, and antiviral TCM were sorted by flow cytometry as CD8+/
CD44low, CD8+/CD44int, and CD8+/CD44high/F5 TCR+, respectively. 
-Galactosidase enzyme activity in splenocytes from XCR1/ mice was 
revealed using FDG as a substrate according to the manufacturer’s instruc-
tions (Invitrogen). In brief, FDG was diluted in warm distilled water at 2 mM, 
and cells were mixed 1:1 with the substrate. After an incubation of one min-
ute at 37°C, cells were placed on ice, and the enzymatic reaction was termi-
nated by adding ice-cold PBS. Cells were stained with a marker of viability 
and promptly acquired by flow cytometry. Sheep CD4+ T, CD8+ T, NK, 
and B cells were enriched from afferent lymph, and monocytes were en-
riched from blood. Sheep leukocytes were stained with mouse mAbs against 
CD1b (clone TH97A; Parsons et al., 1991), CD26 (CC69; Gliddon and 
Howard,  2002),  CD8  (CACT80C;  MacHugh  and  Sopp,  1991),  CD4 JEM VOL. 207, June 7, 2010 
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Multianalyte profiling in supernatant from mouse CD8+ T cells.  
2 × 105 sorted naive CD8+ T cells and TIM were stimulated for 6 h with the 
NP68 peptide at a concentration of 10 nM in 200 µl of medium. Superna-
tants were analyzed using Rodent MAP 1.0 (Rules Based Medicine).
Infections with Lm. The Lm WT strain 10403S and the Lm strain that had 
been engineered to express OVA (Lm-OVA; gift from Grégoire Lauvau, 
Albert Einstein College of Medicine, Bronx, NY) were prepared from 
clones grown from organs of infected mice. Stocks of bacteria were kept 
frozen at 80°C. For infections, a sample of the frozen stock was grown to 
a logarithmic phase (OD600 = 0.05–0.15) in broth heart infusion (BHI) me-
dium (Sigma-Aldrich), diluted in PBS, and injected into the retroorbital 
vein. Bacterial loads in organs were evaluated after infection of mice with 
one LD50 of WT Lm (5 × 104 bacteria). CD8+ T cell responses were mea-
sured in animals infected with 0.1 LD50 of Lm-OVA (5 × 103 bacteria). The 
dose of Lm injected was confirmed by CFU counting of the inoculum. To 
measure bacterial titers, spleens and livers were harvested at day 3 and disso-
ciated on nylon meshes in 5 ml of dissociation buffer (0.2% NP-40). Serial 
dilutions were performed and plated onto BHI agar plates. For analysis of 
Lm-specific CD8+ T cell responses at day 4, OVA-specific CD8+ T cells 
were readily detected using OVA-iTag-H-2Kb-SIINFEKL PE-conjugated 
MHC class I tetramers (Beckman Coulter).
Phylogenetic analysis. 12 representatives of XCR1 sequences were re-
trieved from Ensembl genome assemblies of relevant vertebrate species. No 
good candidate for XCR1 counterpart was found in other phyla. Chromo-
somal  locations  were  obtained  from  Ensembl  (November  2009  release). 
Conserved syntenies were searched manually in Ensembl and with the Ge-
nomicus tool (http://www.dyogen.ens.fr/genomicus/cgi-bin/search.pl). The 
amino acid sequences of XCR1 domain were aligned using ClustalW and 
Mega4 programs. Any site at which the alignment introduces a gap in any 
sequence was excluded, and a comparable set of sites was therefore used for 
the phylogenetic analyses. The phylogenetic analysis was made using two meth-
ods: NJ and parsimony using the MEGA 4 program (Tamura et al., 2007).
Online supplemental material. Fig. S1 documents the expression pattern 
of XCL1 in mouse NK cells, mouse TCM, and human CD8+ T cells during 
viral infections. Fig. S2 shows the alignment of XCR1 protein sequences 
and the Maximum Parsimony phylogenetic analysis of Xcr1 evolution in 
vertebrates. Online supplemental material is available at http://www.jem 
.org/cgi/content/full/jem.20100223/DC1.
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